Basel Medical (BMGL) Long-Term Deferred Tax (2024 - 2025)
Basel Medical (BMGL) posted Long-Term Deferred Tax of $36939.3 for Q4 2025, little changed sequentially from $36779.8 in Q2 2025, and down 52.03% YoY from $77005.0 in Q4 2024.
Basel Medical (BMGL) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Basel Medical has reported Long-Term Deferred Tax for 2 years, with the latest figure at $36939.3 in Q4 2025.
- Quarterly Long-Term Deferred Tax fell 52.03% year-over-year to $36939.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36939.3 (down 52.03% YoY) and the FY2025 annual result came in at $36134.4, down 36.51% from the prior year.
- Long-Term Deferred Tax was little changed at $36939.3 in Q4 2025 per BMGL's latest filing, from $36779.8 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $77005.0 in Q4 2024 and troughed at $36779.8 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | Basel Medical | 98.81 Mn | 98.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36,939.30 |
| Jun 30, 2025 | 36,779.79 |
| Dec 31, 2024 | 77,005.00 |
| Jun 30, 2024 | 56,916.48 |